Table of Contents
Leukemia Research and Treatment
Volume 2011, Article ID 726964, 11 pages
http://dx.doi.org/10.4061/2011/726964
Review Article

Characterization of Kaposi's Sarcoma-Associated Herpesvirus-Related Lymphomas by DNA Microarray Analysis

Division of Virology, Department of Microbiology and Immunology, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan

Received 26 June 2011; Accepted 2 September 2011

Academic Editor: Daniela Cilloni

Copyright © 2011 Keiji Ueda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. M. Howly and D. R. Lowy, Papillomaviruses, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2007.
  2. D. Kremsdorf, P. Soussan, P. Paterlini-Brechot, and C. Brechot, “Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis,” Oncogene, vol. 25, no. 27, pp. 3823–3833, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. M. Levrero, “Viral hepatitis and liver cancer: the case of hepatitis C,” Oncogene, vol. 25, no. 27, pp. 3834–3847, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. M. Matsuoka and K. T. Jeang, “Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation,” Nature Reviews Cancer, vol. 7, no. 4, pp. 270–280, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. L. S. Young and A. B. Rickinson, “Epstein-Barr virus: 40 years on,” Nature Reviews Cancer, vol. 4, no. 10, pp. 757–768, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. A. B. Rickinson and E. Kieff, Epstein-Barr Virus, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2007.
  7. M. Q. Du, H. Liu, T. C. Diss et al., “Kaposi sarcoma-associated herpesvirus infects monotypic (IgMλ) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders,” Blood, vol. 97, no. 7, pp. 2130–2136, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. D. P. McDonagh, J. Liu, M. J. Gaffey, L. J. Layfield, N. Azumi, and S. T. Traweek, “Detection of Kaposi's sarcoma-associated herpesvirus-like DNA sequences in angiosarcoma,” American Journal of Pathology, vol. 149, no. 4, pp. 1363–1368, 1996. View at Google Scholar · View at Scopus
  9. D. Ganem, Kaposi's Sarcoma-Associated Herpesvirus, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2007.
  10. U. R. Hengge, T. Ruzicka, S. K. Tyring et al., “Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: pathogenesis, Castleman's disease, and pleural effusion lymphoma,” Lancet Infectious Diseases, vol. 2, no. 6, pp. 344–352, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. U. R. Hengge, T. Ruzicka, S. K. Tyring et al., “Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy,” Lancet Infectious Diseases, vol. 2, no. 5, pp. 281–292, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. P. S. Moore and Y. Chang, “Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin?” Annual Review of Microbiology, vol. 57, pp. 609–639, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. R. Sarid, S. J. Olsen, and P. S. Moore, “Kaposi's sarcoma-associated herpesvirus: epidemiology, virology, and molecular biology,” Advances in Virus Research, vol. 52, pp. 139–232, 1999. View at Google Scholar · View at Scopus
  14. H. Feng, M. Shuda, Y. Chang, and P. S. Moore, “Clonal integration of a polyomavirus in human Merkel cell carcinoma,” Science, vol. 319, no. 5866, pp. 1096–1100, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. R. Dalla Favera, S. Martinotti, and R. C. Gallo, “Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas,” Science, vol. 219, no. 4587, pp. 963–967, 1983. View at Google Scholar
  16. E. Cesarman and D. M. Knowles, “The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases,” Seminars in Cancer Biology, vol. 9, no. 3, pp. 165–174, 1999. View at Publisher · View at Google Scholar · View at PubMed
  17. S. I. Grivennikov, F. R. Greten, and M. Karin, “Immunity, inflammation, and cancer,” Cell, vol. 140, no. 6, pp. 883–899, 2010. View at Publisher · View at Google Scholar · View at PubMed
  18. D. Elgui de Oliveira, “DNA viruses in human cancer: an integrated overview on fundamental mechanisms of viral carcinogenesis,” Cancer Letters, vol. 247, no. 2, pp. 182–196, 2007. View at Publisher · View at Google Scholar · View at PubMed
  19. B. Damania, “Oncogenic γ-herpesviruses: comparison of viral proteins involved in tumorigenesis,” Nature Reviews Microbiology, vol. 2, no. 8, pp. 656–668, 2004. View at Publisher · View at Google Scholar · View at PubMed
  20. H. Varmus, “Retroviruses,” Science, vol. 240, no. 4858, pp. 1427–1435, 1988. View at Google Scholar
  21. Y. Chang, E. Cesarman, M. S. Pessin et al., “Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma,” Science, vol. 266, no. 5192, pp. 1865–1869, 1994. View at Google Scholar
  22. J. J. Russo, R. A. Bohenzky, M. C. Chien et al., “Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8),” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 25, pp. 14862–14867, 1996. View at Publisher · View at Google Scholar
  23. A. Potthoff, N. H. Brockmeyer, M. Stucker, U. Wieland, A. Kreuter, and H. A. Competence Network, “Kaposi sarcoma in a HIV uninfected man who has sex with men,” European Journal of Medical Research, vol. 15, no. 2, pp. 79–80, 2010. View at Google Scholar
  24. C. Boshoff and R. A. Weiss, “Kaposi's sarcoma-associated herpesvirus,” Advances in Cancer Research, vol. 75, pp. 57–86, 1998. View at Google Scholar
  25. P. P. Naranatt, H. H. Krishnan, S. R. Svojanovsky, C. Bloomer, S. Mathur, and B. Chandran, “Host gene induction and transcriptional reprogramming in kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)-infected endothelial, fibroblast, and B cells: insights into modulation events early during infection,” Cancer Research, vol. 64, no. 1, pp. 72–84, 2004. View at Publisher · View at Google Scholar
  26. K. Ueda, S. Sakakibara, E. Ohsaki, and K. Yada, “Lack of a mechanism for faithful partition and maintenance of the KSHV genome,” Virus Research, vol. 122, no. 1-2, pp. 85–94, 2006. View at Publisher · View at Google Scholar · View at PubMed
  27. L. Arvanitakis, E. A. Mesri, R. G. Nador et al., “Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus,” Blood, vol. 88, no. 7, pp. 2648–2654, 1996. View at Google Scholar
  28. K. Nishimura, K. Ueda, S. Sakakibara et al., “Functional analysis of Kaposi's sarcoma-associated herpesvirus RTA in an RTA-depressed cell line,” Journal of Human Virology, vol. 4, no. 6, pp. 296–305, 2001. View at Google Scholar
  29. N. Shimizu, A. Tanabe-Tochikura, Y. Kuroiwa, and K. Takada, “Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV- positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV,” Journal of Virology, vol. 68, no. 9, pp. 6069–6073, 1994. View at Google Scholar
  30. K. Ueda, E. Ito, M. Karayama, E. Ohsaki, K. Nakano, and S. Watanabe, “KSHV-infected PEL cell lines exhibit a distinct gene expression profile,” Biochemical and Biophysical Research Communications, vol. 394, no. 3, pp. 482–487, 2010. View at Publisher · View at Google Scholar · View at PubMed
  31. H. Katano, Y. Hoshino, Y. Morishita et al., “Establishing and characterizing a CD30-positive cell line harboring HHV- 8 from a primary effusion lymphoma,” Journal of Medical Virology, vol. 58, no. 4, pp. 394–401, 1999. View at Publisher · View at Google Scholar
  32. R. Renne, W. Zhong, B. Herndier et al., “Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture,” Nature Medicine, vol. 2, no. 3, pp. 342–346, 1996. View at Publisher · View at Google Scholar
  33. E. Cesarman, P. S. Moore, P. H. Rao, G. Inghirami, D. M. Knowles, and Y. Chang, “In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences,” Blood, vol. 86, no. 7, pp. 2708–2714, 1995. View at Google Scholar
  34. K. Takada, K. Horinuchi, Y. Ono et al., “An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA,” Virus Genes, vol. 5, no. 2, pp. 147–156, 1991. View at Google Scholar
  35. B. Herndier and D. Ganem, “The biology of Kaposi's sarcoma,” Cancer Treatment and Research, vol. 104, pp. 89–126, 2001. View at Google Scholar
  36. S. A. Miles, “Kaposi sarcoma: a cytokine-responsive neoplasia?” Cancer Treatment and Research, vol. 63, pp. 129–140, 1992. View at Google Scholar
  37. H. W. Wang, M. W. B. Trotter, D. Lagos et al., “Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma,” Nature Genetics, vol. 36, no. 7, pp. 687–693, 2004. View at Publisher · View at Google Scholar · View at PubMed
  38. Y. K. Hong, K. Foreman, J. W. Shin et al., “Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus,” Nature Genetics, vol. 36, no. 7, pp. 683–685, 2004. View at Publisher · View at Google Scholar · View at PubMed
  39. M. Weinreb, P. J. Day, F. Niggli et al., “The role of Epstein-Barr virus in Hodgkin's disease from different geographical areas,” Archives of Disease in Childhood, vol. 74, no. 1, pp. 27–31, 1996. View at Google Scholar
  40. L. L. Decker, P. Shankar, G. Khan et al., “The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients,” Journal of Experimental Medicine, vol. 184, no. 1, pp. 283–288, 1996. View at Publisher · View at Google Scholar
  41. J. Chen, K. Ueda, S. Sakakibara, T. Okuno, and K. Yamanishi, “Transcriptional regulation of the Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor gene,” Journal of Virology, vol. 74, no. 18, pp. 8623–8634, 2000. View at Publisher · View at Google Scholar
  42. K. Yada, E. Do, S. Sakakibara et al., “KSHV RTA induces a transcriptional repressor, HEY1 that represses rta promoter,” Biochemical and Biophysical Research Communications, vol. 345, no. 1, pp. 410–418, 2006. View at Publisher · View at Google Scholar · View at PubMed
  43. A. Chadburn, E. M. Hyjek, W. Tam et al., “Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD),” Histopathology, vol. 53, no. 5, pp. 513–524, 2008. View at Publisher · View at Google Scholar · View at PubMed
  44. E. Oksenhendler, M. Duarte, J. Soulier et al., “Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients,” Aids, vol. 10, no. 1, pp. 61–67, 1996. View at Google Scholar
  45. D. Dittmer, C. Stoddart, R. Renne et al., “Experimental transmission of kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SCID-hu Thy/Liv mice,” Journal of Experimental Medicine, vol. 190, no. 12, pp. 1857–1868, 1999. View at Publisher · View at Google Scholar
  46. T. S. Uldrick, V. Wang, D. O'Mahony et al., “An interleukin-6-related systemic inflammatory syndrome in patients co-infected with kaposi sarcoma-associated herpesvirus and HIV but without multicentric castleman disease,” Clinical Infectious Diseases, vol. 51, no. 3, pp. 350–358, 2010. View at Publisher · View at Google Scholar · View at PubMed
  47. C. Parravicini, B. Chandran, M. Corbellino et al., “Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease,” American Journal of Pathology, vol. 156, no. 3, pp. 743–749, 2000. View at Google Scholar
  48. R. Hamoudi, T. C. Diss, E. Oksenhendler et al., “Distinct cellular origins of primary effusion lymphoma with and without EBV infection,” Leukemia Research, vol. 28, no. 4, pp. 333–338, 2004. View at Publisher · View at Google Scholar · View at PubMed
  49. A. Matolcsy, R. G. Nador, E. Cesarman, and D. M. Knowles, “Immunoglobulin V(H) gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation,” American Journal of Pathology, vol. 153, no. 5, pp. 1609–1614, 1998. View at Google Scholar
  50. R. Kuppers, “Mechanisms of B-cell lymphoma pathogenesis,” Nature Reviews Cancer, vol. 5, no. 4, pp. 251–262, 2005. View at Publisher · View at Google Scholar · View at PubMed
  51. R. Taub, I. Kirsch, and C. Morton, “Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 79, no. 24, pp. 7837–7841, 1982. View at Google Scholar
  52. F. Baran-Marszak, R. Fagard, B. Girard et al., “Gene array identification of Epstein Barr virus-regulated cellular genes in EBV-converted Burkitt lymphoma cell lines,” Laboratory Investigation, vol. 82, no. 11, pp. 1463–1479, 2002. View at Google Scholar · View at Scopus
  53. J. Yuan, E. Cahir-McFarland, B. Zhao, and E. Kieff, “Virus and cell RNAs expressed during Epstein-Barr virus replication,” Journal of Virology, vol. 80, no. 5, pp. 2548–2565, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus